RITUXIMAB AMRING PHARMA 100MG/10ML – 1
KSh65,340.00
Rituximab, marketed as Amring 100mg/10ml, is a monoclonal antibody primarily used in the treatment of certain types of cancers and autoimmune diseases. Its main uses include the treatment of non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and rheumatoid arthritis in patients who have not responded adequately to other therapies.
Rituximab works by targeting the CD20 protein found on the surface of B-cells, leading to the destruction of these cells, which are often involved in the pathogenesis of these diseases. In oncology, it helps to reduce tumor size and improve survival rates, while in autoimmune conditions, it helps to decrease inflammation and modulate the immune response.
Overall, Rituximab is a critical therapeutic agent in oncology and rheumatology, providing significant benefits to patients with B-cell malignancies and autoimmune disorders.
